Breaking News
April 22, 2019 - The U.S government may account for up to $37.8 billion due to opioid epidemic
April 22, 2019 - Improving ACA’s Insurance Coverage Provisions will lead to better care for patients
April 22, 2019 - Study identifies possible therapeutic effects of curcumin on stomach cancer
April 22, 2019 - Hyaline fibromatosis syndrome – Genetics Home Reference
April 22, 2019 - Scientists use CRISPR for possible ‘bubble boy’ therapy
April 22, 2019 - Hematologist (and a mom, singer, actress and much more) stands up for diversity
April 22, 2019 - Novel AI voice tool can help diagnose PTSD
April 22, 2019 - Overlooked part of cell’s internal machinery may hold key to treating acute myeloid leukemia
April 22, 2019 - MIT scientists reverse some behavioral symptoms of rare neurodevelopmental disorder
April 22, 2019 - Scientists find new therapy target for drug-induced liver failure
April 22, 2019 - Opioid dose variability could lead to increased risk of overdose, study suggests
April 22, 2019 - Newly developed model predicts salmonella outbreaks several months in advance
April 22, 2019 - Deep-learning model better predicts survival outcomes for lung cancer
April 22, 2019 - One in Three U.S. Adults Aged 35 to 44 May Have Drinking Problem
April 22, 2019 - Why the measles virus is so contagious
April 22, 2019 - Magnet ‘Zap’ to the Brain Might Jumpstart Aging Memory
April 22, 2019 - Immune response to gut microbes may be early indicator of type 1 diabetes
April 22, 2019 - Destination Limbo: Health Suffers Among Asylum Seekers In Crowded Border Shelter
April 22, 2019 - Research shows how dopamine contributes to sex differences in worms
April 22, 2019 - Marijuana users weigh less compared to non-users
April 22, 2019 - Research uncovers critical RNA processing aberrations in ALS and FTD
April 22, 2019 - Many cancer patients use marijuana and prescription opioids, study reveals
April 22, 2019 - Frailty may up fracture risk in patients with type 2 diabetes
April 22, 2019 - Study provides new insight into how obesity, insulin resistance can affect cognition
April 22, 2019 - Study seeks to better understand the genetic causes for hypospadias
April 22, 2019 - FDA grants approval of first generic naloxone nasal spray to treat opioid overdose
April 22, 2019 - FDA authorizes marketing of first medical device to treat ADHD
April 22, 2019 - Vanderbilt researchers to develop and test ‘safe harbor’ standards of care
April 22, 2019 - You’re probably brushing your teeth wrong – here are four tips for better dental health
April 22, 2019 - Pharmacy closures contribute to medication non-adherence among heart patients
April 22, 2019 - Using Edge AI technology to observe behavior of cattle
April 22, 2019 - Bacteria play a role in the development of stomach ulcers in pigs
April 22, 2019 - Hand Hygiene Compliance Poor in Task Transitions
April 22, 2019 - smoking could harm your baby
April 22, 2019 - Scientists identify rare, paradoxical response to antiretroviral therapy
April 21, 2019 - More TV, Tablets, More Attention Issues at Age 5
April 21, 2019 - Drug reduces risk of kidney failure in people with diabetes, study finds
April 21, 2019 - New research identifies novel link between antibiotic resistance and climate change
April 21, 2019 - Simple intervention can provide lasting protection for teens against junk food marketing
April 21, 2019 - The protein p38-gamma identified as a new therapeutic target in liver cancer
April 21, 2019 - Novel system enables researchers to study bacteria within mini-tissues in a dish
April 21, 2019 - Discovery of oral cancer biomarkers could save thousands of lives
April 21, 2019 - Geneva Exhibition committee gives gold medals to two medications developed by Kazan
April 21, 2019 - Scientists aim to minimize or eliminate hair loss during cancer treatment
April 21, 2019 - WiFi interacts with signaling pathways in the human brain
April 21, 2019 - Stroke Hospitalizations Down in Black, White Medicare Enrollees
April 21, 2019 - First common risk genes discovered for autism
April 21, 2019 - Researchers map auditory sensory system of the mouse brain
April 21, 2019 - Scientists Bring Pig’s Brain, Dead 4 Hours, Back to ‘Cellular Activity’
April 21, 2019 - Virtual reality a promising tool for reducing fears and phobia in autism
April 21, 2019 - New analysis lists out opportunities for U.S. medical schools to advance population health
April 21, 2019 - More sleep may help teens with ADHD focus and organize
April 21, 2019 - Breakthrough antibody treatment suppresses HIV without antivirals
April 21, 2019 - AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA) Type 1
April 21, 2019 - Is your hand pain arthritis, carpal tunnel or something else?
April 21, 2019 - Measles outbreaks may become more frequent if vaccination rates continue to decline
April 21, 2019 - Researchers succeed in accelerating process of creating 3D images
April 21, 2019 - Tiny worm mimics key genetic risk for Alzheimer’s
April 21, 2019 - Angry dreams explained by brain waves
April 20, 2019 - Parenteral Antimicrobial Tx at Home Burdens Children’s Caregivers
April 20, 2019 - Diabetes treatment may keep dementia, Alzheimer’s at bay
April 20, 2019 - New bandage-like biosensor collects and analyzes sweat
April 20, 2019 - A comprehensive, centralized database of bovine milk compounds
April 20, 2019 - Two new epigenetic regulators maintain self-renewal of embryonic stem cells
April 20, 2019 - New Evidence That Veggies Beat Steak for Heart Health
April 20, 2019 - Study reveals genes associated with heavy drinking and alcoholism
April 20, 2019 - Texas A&M AgriLife becomes the newest member of NutriRECS international consortium
April 20, 2019 - In most states, insurance won’t cover addiction treatments
April 20, 2019 - Computer-based memory games may be beneficial for individuals with fragile X syndrome
April 20, 2019 - Timing of food intake influences molecular clock in the liver of mice
April 20, 2019 - Precise decoding of breast cancer cells paves way for new treatment option
April 20, 2019 - Scientists use 3D imaging to help model complex processes performed by placenta
April 20, 2019 - MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
April 20, 2019 - Genetic variants that protect against obesity could aid new weight loss medicines
April 20, 2019 - New technology developed for microscopic imaging in living organisms
April 20, 2019 - when quitting cigarettes, consider using more nicotine, not less
April 20, 2019 - Key proteins can block Listeria without triggering the death of host cells
April 20, 2019 - Researchers create a working model of cerebral tract to study brain function
April 20, 2019 - New study shows that microbes can help break toxic chemical in dust
April 20, 2019 - Scientists use NIR light and injected DNA nanodevice to guide stem cells to injury
Mystery novel and dream spur key scientific insight into heart defect | News Center

Mystery novel and dream spur key scientific insight into heart defect | News Center

image_pdfDownload PDFimage_print

A cardiac muscle cell contains perhaps a hundred repeating structural subunits called sarcomeres, arranged one after another in a series. A sarcomere is composed of myosin-rich “thick filaments” alternating with parallel “thin filaments” made of actin.

Closer inspection reveals that each thick filament is knitted from the bottom halves of myosin molecules’ tails. In response to electrical impulses traversing the heart, the myosin heads protruding from the thick filament chomp down on the nearest actin filament, then tug against it like sailors tugging in tandem on a rope, pulling the sarcomere walls closer together and making the muscle fiber contract, before relaxing again.

That’s a heartbeat. And if those myosin sailors are tugging too hard on those actin ropes? That’s hypercontractility, the hallmark of HCM. 

But why would this happen? 

About 35 to 40 percent of all known HCM-inducing mutations are in cardiac myosin, making it an obvious candidate for intense scrutiny. But until about a dozen years ago, nobody could study the effects of cardiac myosin mutations, Spudich said, because the biotechnology for making significant amounts of it that would work didn’t exist yet. 

Then one of his frequent collaborators at the University of Colorado figured out a way to pull it off. Spudich dropped everything else he’d been doing and began systematically characterizing the effects of HCM-inducing mutations on the function of cardiac myosin molecules, asking: Why would so many diverse mutations all cause myosin to be hypercontractile?

Most of these mutations pop up on the molecule’s head. Another big batch are in the top part of its tail. Spudich hypothesized that the mutations somehow made each individual cardiac-myosin molecule faster-moving or more forceful than normal.

“But in the many mutations we studied, neither molecular speed nor strength were accounting for mutation-induced hypercontractility,” he said. “We were missing something.”


On Dec. 14, 2014, after many months of not getting expected results, Spudich lay awake in bed late at night wondering what clue he’d been overlooking.

“For just one night, stop thinking about your work,” Anna told him. She gave him a book she was sure he was going to like: The Haunted Mesa, by Louis L’Amour. The book’s plot unfolded in the setting of a Southwestern mesa similar to many Spudich had spied from above during his airborne sojourns in the Southwest.

He nodded off about 20 pages in, awakening hours later from a vivid dream in which the image of a mesa morphed into a myosin molecule. 

It was 5:30 a.m. Aflame with inspiration, Spudich jumped out of bed and beelined to his computer, a new hypothesis in his head. 

Protein molecules are born as linear sequences of chemical building blocks called amino acids, but that one-dimensionality doesn’t last long. Almost as soon as each molecule gets produced in a cell, it folds up into a characteristic three-dimensional shape it will retain for the rest of its working life.

With molecular-modeling software now widely available, researchers including Spudich can speedily rotate a molecule of interest in any of three dimensions onscreen. Viewed from the right perspective, one part of the myosin head’s surface is a broad expanse, as flat as the mesa of the dream that had just awakened the sleeping scientist. 

Those who study myosin have known about this mesalike surface since 1993, Spudich said. But until now, nobody had given much thought to its significance. 

Every amino acid sequence of a protein molecule is specified by the gene encoding that particular protein. There are 20 different amino acid varieties to choose from, each with its own distinctive biochemical quirks: for example, a negative versus positive versus neutral electrical charge.

One typical type of mutation results in the substitution of one amino acid for another.

Spudich’s team had previously generated computer models flagging points along cardiac myosin’s linear sequence where a mutated amino acid had been found to cause HCM. These mutations’ locations seemed to be scattered pretty randomly along the molecule.

But viewed on the properly folded molecule, as Spudich was now doing, many of these mutations could be seen to fall somewhere on the mesalike surface of the head of myosin. Many others fell along the part of the tail against which the head rested when the molecule was assuming its “sleeping” position.

All hands on deck

Spudich’s group had been studying 15 or so of the most common HCM-inducing cardiac myosin mutations. They knew that most of those mutations had the effect of changing or eliminating the electrical charge the amino acid in the unmutated molecule would have had.

Now it hit him: Opposites attract. Surfaces with lots of positive charges on them are drawn to surfaces with lots of negative charges on them. Any mutation that reduces this charge opposition could result in the myosin head’s spending less time tucked up against its tail and more time on duty tugging on its nearby actin filament. These mutations aren’t changing myosin molecules’ strength or speed; they’re just making more heads available to do the tugging. 

What Spudich and others had been overlooking was this: Most of the time, many of the myosin heads in the thick filament are on break — at least in healthy heart muscle. Thick fibers normally host a huge reserve army of loafing myosin heads, which is a good thing; those loafing heads can be recruited by normal physiological responses when needed. But HCM mutations effectively nudge them back on the job, even when they’re not needed.

You’ve been thinking and thinking and thinking about something for such a long time. Then suddenly the dream solves the puzzle for you.

A sarcomere’s contractile force, Spudich reasoned, is proportional to the number of myosin heads that are “grabbing” onto the actin filament at any given moment. Normally, the mesalike surface of a cardiac myosin molecule spends much of its time in coordinated proximity with a portion of the “tail” section, sequestering the head so it can’t grab the actin filament.

Looking at the folded cardiac-myosin molecule on his computer screen, Spudich realized that by weakening the overall attraction between a myosin molecule’s head and tail, HCM-inducing mutations were freeing up myosin heads to grab onto a neighboring actin filament, increasing the number of myosin heads actually pulling their weight at any one time. Hence, the hypercontractile heart. Not quite proof, but a hypothesis with a bright future.

Spudich’s group has since shown that mutations at these suspect sites do actually alter cardiac myosin’s posture and put more heads in play. A 2018 paper in Proceedings of the National Academy of Sciences co-authored by Spudich suggested that a drug called mavacamten, now in phase-3 clinical trials for HCM, may be successful in reversing the hypercontractility induced by a wide range of HCM-inducing mutations on the myosin mesa.

All patients in two earlier trials of mavacamten showed significant improvement. These trials have been sponsored by a South San Francisco-based biotechnology company, MyoKardia Inc., that Spudich co-founded in 1998 to speed the translation of his findings into drugs that could be used in clinical practice to treat HCM. Mavacamten was the fruit of this discovery effort.

“The drug is pushing available heads into the unavailable state — the opposite of what I believe most of these mutations are doing,” Spudich said. 

In principle, this approach might apply to most HCM-causing mutations. 

As for The Haunted Mesa, Spudich eventually finished it and, he said, enjoyed it. But the thing that sticks with him was that image of a mesa and its prophetic power, as revealed in his dream that night.

What if Spudich’s wife hadn’t given him that book to read that night? “I think someone else would have stumbled on the same idea,” he said. “The dream just jump-started it, accelerating progress by a number of years.”

For this, all hail Morpheus. “Sleep is amazing,” Spudich said. “You’ve been thinking and thinking and thinking about something for such a long time. Then suddenly the dream solves the puzzle for you.”

Tagged with:

About author

Related Articles